Cargando…

Abstract 1 Clinical and Imaging Outcomes After Allogenic Umbilical Cord Blood Transfusions in a Young Adult with Cerebral Palsy

INTRODUCTION: Umbilical cord blood transplant is an emerging promising therapy for cerebral palsy. Here we report a case of a 23-year-old spastic quadriplegic young adult whose motor and cognitive function improved after allogenic umbilical cord blood transfusion. METHODS: The patient received three...

Descripción completa

Detalles Bibliográficos
Autores principales: Tseng, Sung Hui, Lu, Long-Sheng, Kuo, Chen-Yuan, Lin, Ching Po, Yeh, Tu-Hsueh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476942/
http://dx.doi.org/10.1093/stcltm/szad047.002
_version_ 1785101040466526208
author Tseng, Sung Hui
Lu, Long-Sheng
Kuo, Chen-Yuan
Lin, Ching Po
Yeh, Tu-Hsueh
author_facet Tseng, Sung Hui
Lu, Long-Sheng
Kuo, Chen-Yuan
Lin, Ching Po
Yeh, Tu-Hsueh
author_sort Tseng, Sung Hui
collection PubMed
description INTRODUCTION: Umbilical cord blood transplant is an emerging promising therapy for cerebral palsy. Here we report a case of a 23-year-old spastic quadriplegic young adult whose motor and cognitive function improved after allogenic umbilical cord blood transfusion. METHODS: The patient received three times of cord blood transfusion intravenously (2022/2/15, 2022/05/16, 2022/8/15). Each cord blood was 4/6 HLA-matched and contained 10 × 107 total nucleated cells (TNC)/kg. RESULTS: The young man was born preterm. Due to motor developmental delay, he began rehabilitation when 1-year-old. His best mobility function was GMFCS III. At the age of 18, there was a rapid decline of his mobility. EEG showed seizure like waves and TRODAT brain scan on 2018/9/28 revealed symmetric mild striatal dopaminergic neuron loss. He was totally ADL dependent and mobility and communication severely restricted due to strong spasticity and rigidity. 3 days after 1st cord blood transfusion, he walked 500 steps (1 km/h) on LOKOMAT with 100% guidance force and 50% body weight supported. In the 16th session (when he also completed the 3(rd) cord blood transfusion), he walked1000 steps (1.5 km/h) on LOKOMAT with 90% guidance force and 50% body weight supported. Afterward, he regained sufficient motor function to maintain daily training with traditional physiotherapy. There was no adverse event during all the transplant procedures. Brain images taken before and after cord blood transfusion were compared with a brain-age predicting model to obtain differences in predicted and chronological age in 3 sets of brain images. The result showed reduced differences between predicted and chronological brain age (Figure 1). His mother reported that he became more alert and more responsive during interaction. DISCUSSIO: This case highlights the therapeutic effect of allogenic umbilical cord blood transfusion to benefit adult CP manifest deterioration in physical activity and cognitive function. The specific mechanisms involved in this process are not yet fully understood. Therefore, any use of stem cell transplantation for the treatment of cerebral palsy should be done under the guidance of good clinical practice to accumulate robust real-world data, and more research is needed to fully understand its mechanisms of action. [Image: see text]
format Online
Article
Text
id pubmed-10476942
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-104769422023-09-05 Abstract 1 Clinical and Imaging Outcomes After Allogenic Umbilical Cord Blood Transfusions in a Young Adult with Cerebral Palsy Tseng, Sung Hui Lu, Long-Sheng Kuo, Chen-Yuan Lin, Ching Po Yeh, Tu-Hsueh Stem Cells Transl Med Clinical Trials – Hematopoietic Stem Cell Therapy INTRODUCTION: Umbilical cord blood transplant is an emerging promising therapy for cerebral palsy. Here we report a case of a 23-year-old spastic quadriplegic young adult whose motor and cognitive function improved after allogenic umbilical cord blood transfusion. METHODS: The patient received three times of cord blood transfusion intravenously (2022/2/15, 2022/05/16, 2022/8/15). Each cord blood was 4/6 HLA-matched and contained 10 × 107 total nucleated cells (TNC)/kg. RESULTS: The young man was born preterm. Due to motor developmental delay, he began rehabilitation when 1-year-old. His best mobility function was GMFCS III. At the age of 18, there was a rapid decline of his mobility. EEG showed seizure like waves and TRODAT brain scan on 2018/9/28 revealed symmetric mild striatal dopaminergic neuron loss. He was totally ADL dependent and mobility and communication severely restricted due to strong spasticity and rigidity. 3 days after 1st cord blood transfusion, he walked 500 steps (1 km/h) on LOKOMAT with 100% guidance force and 50% body weight supported. In the 16th session (when he also completed the 3(rd) cord blood transfusion), he walked1000 steps (1.5 km/h) on LOKOMAT with 90% guidance force and 50% body weight supported. Afterward, he regained sufficient motor function to maintain daily training with traditional physiotherapy. There was no adverse event during all the transplant procedures. Brain images taken before and after cord blood transfusion were compared with a brain-age predicting model to obtain differences in predicted and chronological age in 3 sets of brain images. The result showed reduced differences between predicted and chronological brain age (Figure 1). His mother reported that he became more alert and more responsive during interaction. DISCUSSIO: This case highlights the therapeutic effect of allogenic umbilical cord blood transfusion to benefit adult CP manifest deterioration in physical activity and cognitive function. The specific mechanisms involved in this process are not yet fully understood. Therefore, any use of stem cell transplantation for the treatment of cerebral palsy should be done under the guidance of good clinical practice to accumulate robust real-world data, and more research is needed to fully understand its mechanisms of action. [Image: see text] Oxford University Press 2023-09-04 /pmc/articles/PMC10476942/ http://dx.doi.org/10.1093/stcltm/szad047.002 Text en © The Author(s) 2023. Published by Oxford University Press. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Clinical Trials – Hematopoietic Stem Cell Therapy
Tseng, Sung Hui
Lu, Long-Sheng
Kuo, Chen-Yuan
Lin, Ching Po
Yeh, Tu-Hsueh
Abstract 1 Clinical and Imaging Outcomes After Allogenic Umbilical Cord Blood Transfusions in a Young Adult with Cerebral Palsy
title Abstract 1 Clinical and Imaging Outcomes After Allogenic Umbilical Cord Blood Transfusions in a Young Adult with Cerebral Palsy
title_full Abstract 1 Clinical and Imaging Outcomes After Allogenic Umbilical Cord Blood Transfusions in a Young Adult with Cerebral Palsy
title_fullStr Abstract 1 Clinical and Imaging Outcomes After Allogenic Umbilical Cord Blood Transfusions in a Young Adult with Cerebral Palsy
title_full_unstemmed Abstract 1 Clinical and Imaging Outcomes After Allogenic Umbilical Cord Blood Transfusions in a Young Adult with Cerebral Palsy
title_short Abstract 1 Clinical and Imaging Outcomes After Allogenic Umbilical Cord Blood Transfusions in a Young Adult with Cerebral Palsy
title_sort abstract 1 clinical and imaging outcomes after allogenic umbilical cord blood transfusions in a young adult with cerebral palsy
topic Clinical Trials – Hematopoietic Stem Cell Therapy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476942/
http://dx.doi.org/10.1093/stcltm/szad047.002
work_keys_str_mv AT tsengsunghui abstract1clinicalandimagingoutcomesafterallogenicumbilicalcordbloodtransfusionsinayoungadultwithcerebralpalsy
AT lulongsheng abstract1clinicalandimagingoutcomesafterallogenicumbilicalcordbloodtransfusionsinayoungadultwithcerebralpalsy
AT kuochenyuan abstract1clinicalandimagingoutcomesafterallogenicumbilicalcordbloodtransfusionsinayoungadultwithcerebralpalsy
AT linchingpo abstract1clinicalandimagingoutcomesafterallogenicumbilicalcordbloodtransfusionsinayoungadultwithcerebralpalsy
AT yehtuhsueh abstract1clinicalandimagingoutcomesafterallogenicumbilicalcordbloodtransfusionsinayoungadultwithcerebralpalsy